Anna Eshoo actually said...

"You did a great job, and I think that you answered--with your answers you were highly instructive to all of the members of the committee."

"They are so hungry and so in need of these changes."

"I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's."

"I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic."